Welcome to our dedicated page for NOVONIX SEC filings (Ticker: NVNXF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
NOVONIX Limited filings document foreign-issuer reports furnished on Form 6-K, with exhibits drawn from ASX announcements and corporate notices. The record includes disclosures on annual general meeting presentations and voting results, material-event updates, material agreements, operating and financial results, and governance matters tied to the company's battery materials business.
Capital-structure filings cover applications for quotation of ordinary fully paid securities, securities issued from option exercises or convertible-security conversions, performance rights, and director interest notices. These filings also record shareholder voting matters and formal updates relevant to NOVONIX's ADR and foreign-issuer reporting framework.
Novonix Limited filed a Form 6-K as a foreign private issuer, mainly to provide investors with an attached ASX announcement titled “NOVONIX Achieves Critical Operational Milestone” dated October 15, 2025. The report is signed by the company’s Chief Financial Officer, Robert Long, indicating this operational milestone is significant enough to be formally furnished to U.S. markets, although specific details are contained in the referenced exhibit.
NOVONIX Limited furnished a Form 6-K as a foreign private issuer. The filing presents an Exhibit 99.1 titled “Appendix 2A (Application for quotation of securities)” dated October 15, 2025.
The report was signed on behalf of NOVONIX by Chief Financial Officer Robert Long. This submission updates U.S. investors with the attached application related to the quotation of securities.
Novonix Limited, an Australia-based foreign private issuer, filed a Form 6-K for October 2025. The filing primarily forwards an attached document, Exhibit 99.1, which is an Appendix 2A Application for quotation of securities dated October 08, 2025.
The report is signed on behalf of Novonix by Chief Financial Officer Robert Long, confirming the company’s submission of this securities quotation application to the market under U.S. reporting rules.